Home / Products / Antibiotics / LOVOX- 500
Click image to inspect pack details
Antibiotics Marketed by Aerochem Neutron

LOVOX- 500

Formulation Code AC-483
Commercial Status Active Product Information Available

Product Overview & Formulation Profile

Description

Composition: Levofloxacin 500mg (tablets). Its activity comes from a single component, Levofloxacin (fluoroquinolone antibacterial).

Levofloxacin is a fluoroquinolone that inhibits bacterial DNA gyrase and topoisomerase IV.

LOVOX is a prescription medicine from Aerochem Neutron's antibiotic range, for use on the prescription of a registered medical practitioner.

Composition & Formulation Details

Features

·       Contains Levofloxacin 500mg

·       Levofloxacin — fluoroquinolone that inhibits bacterial DNA gyrase and topoisomerase IV

·       Presented as tablets

·       Prescription-only medicine

Conditions

·       Community-acquired pneumonia and acute bacterial exacerbation of chronic bronchitis

·       Acute bacterial sinusitis

·       Urinary tract infections, including pyelonephritis

·       Skin and soft-tissue infections

·       Other indications as per the approved prescribing information

Safety

·       Contraindicated in patients with known hypersensitivity to any component.

·       Fluoroquinolones carry warnings for tendinitis and tendon rupture, peripheral neuropathy, CNS effects, QT prolongation, dysglycaemia and aortic aneurysm risk, and can worsen myasthenia gravis; reserve for situations where they are clearly appropriate and avoid in pregnancy and in children unless benefits outweigh risks.

·       Refer to the full prescribing information for all contraindications and interactions.

Clinical Rationale: The mechanisms and labelled uses of levofloxacin described here follow the US prescribing information (DailyMed); the EMA 2018 fluoroquinolone review restricted these agents because of disabling and potentially long-lasting adverse effects, which is why use should be limited to cases where they are clearly appropriate; antibiotic choice should follow local resistance data and the WHO AWaRe antibiotic book.

References (Verified)

·       DailyMed (US NLM) prescribing information – levofloxacin: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=LEVOFLOXACIN

·       EMA – Quinolone and fluoroquinolone medicines referral (2018): https://www.ema.europa.eu/en/medicines/human/referrals/quinolone-fluoroquinolone-containing-medicinal-products

·       WHO AWaRe (Access, Watch, Reserve) antibiotic book (2022): https://www.who.int/publications/i/item/9789240062382

Professional Product Enquiries

Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.

Product Information

Review verified active composition, strength, dosage form, and packaging details on this page.

View Specifications

Healthcare Professional Enquiry

Request formulation literature, technical specifications, or product communication from our commercial team.

Submit Product Enquiry

Commercial Supply Enquiry

Connect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.

Commercial Enquiry

Professional Product Information

This product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.

Product Enquiry

Request Formulation Details

Request information about LOVOX- 500 for professional use.

Please enter the numeric sum to verify you are a human visitor.
Therapeutic Alternatives

Related Formulations

SULTAVIN Formulation
AEROCLAV -625 Formulation
AEROFLOX 200 Formulation
A.G 250 Formulation
Product Information

Need specifications for this formulation?

Request verified product information for professional use, or send a separate business enquiry for manufacturing or partnership discussions.

WhatsApp: +91 9512047000